Lakefront Biotherapeutics Total Liabilities

Lakefront Biotherapeutics (GLPG.AS) currently reports a total liabilities of $120M as of March 2026. That compares with $1.3B in the prior-year period — down 90.7% year over year. Use the charts on this page to explore Lakefront Biotherapeutics's total liabilities history and peer comparisons.

Lakefront Biotherapeutics's total liabilities decreased from $1.3B to $120M — a 90.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lakefront Biotherapeutics reported $120M in total liabilities as of March 2026. That compares with $1.3B in the prior-year period — down 90.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lakefront Biotherapeutics, and consider following GLPG.AS for alerts when major investors trade the stock.

Lakefront Biotherapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLPG.AS with unrelated industries.